Synergy Pharmaceuticals (NASDAQ: SGYP) Synergy Pharmaceuticals is having a decent day in the market today as the stock works on a recovery from Friday’s and Monday’s market-wide declines. In my opinion, a strong recovery is long over due. Today, we’ll talk about what we’re seeing in the market, why SGYP is a strong opportunity for … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) Synergy Pharmaceuticals has been having a rough time in the market lately and the crash in the stock market didn’t make things much better. However, today Synergy Pharmaceuticals seems to be one of the stocks that is recovering from declines most quickly. And, in my opinion, it’s for a good reason. … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) Synergy Pharmaceuticals has been an incredibly interesting stock to watch recently. After releasing positive results from the second phase 3 study of Plecanatide, we recently saw massive gains in the stock. However, since then, we’ve seen ups and downs, but no real, lasting movement in either direction. Today, we’ll take … Read more
Nymox Pharmaceutical (NASDAQ:NYMX) On July 27, 2015 Nymox surged as high as 100% after the company reported positive phase 3 results for its BPH study. BPH stands for benign prostatic hyperplasia, and is characterized by an enlarged prostate gland. This enlarged prostate gland causes problems such as problems of urinating or the need to urinate … Read more
Synergy Pharmaceuticals (NASDAQ: SGYP) Synergy Pharmaceuticals has been a very interesting stock to watch as of late. Recently, the company released top-line data from the second of two Phase 3 studies looking into the experimental drug, plecanatide. The results showed that SGYP met its primary endpoint and pointed to an upcoming NDA. While we saw … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) Synergy Pharmaceuticals is seeing strong growth; a continuation of momentum caused by yesterday’s big announcement that plecanatide met the primary endpoint in the second of two phase 3 studies. Today, we’ll take a look at the movement we’re seeing in the market and talk about what we can expect to … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) Synergy Pharmaceuticals is having a great day in the market today after releasing data from their second of two Phase 3 studies looking into the experimental drug plecanatide. Today, we’ll take a look at the details of the study results, how the market reacted, and discuss what we can expect … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) Synergy Pharmaceuticals has been a very interesting stock to watch lately. After releasing data from it’s Phase 3-A study into the effectiveness of plecanatide, SGYP soared In the market. However, since then, we’ve seen declines overall. Today, we’ll talk about what we’ve seen from SGYP and signs that the stock … Read more
Synergy Pharmaceuticals Inc (NASDAQ: SGYP) Synergy Pharmaceuticals stock has been one of my favorite topics recently. The company’s advancements with regard to their experimental drug, known as plecanatide, have been incredible. Now, the company is giving investors even more reason to put on the bullish face. They have brought on a new executive to help … Read more
\Synergy Pharmaceuticals Inc (NASDAQ: SGYP) If you have followed my work here or elsewhere, you know that I’ve been tracking Synergy Pharmaceuticals for quite some time now. The bottom line is that when we talk about Synergy, we’re talking about a strong company with a strong stock; and the price action we’ve seen over the … Read more